MIAMI—Mission 500, the security industry's nonprofit charity dedicated to supporting children in need across the U.S., Canada, and Puerto Rico, has unveiled a refreshed brand identity ahead of ISC ...

Analysts have recently evaluated Emergent BioSolutions and provided 12-month price targets. The average target is $15.0, ...

Emergent BioSolutions Inc. (NYSE:EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, today announced that its Compensation ...

Vinay Singh, Oracle Fusion Cloud, and AI-ERP integration expert, delivers enterprise solutions that improve financial and ...

SANTA CLARA, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (NASDAQ: PDFS), today announced it has closed the acquisition of secureWISE, LLC, a widely used secure, remote ...

Vancouver Island trucking and warehouse provider ColdStar Solutions has been purchased by Federated Co-operatives Ltd. (FCL), the companies announced March 6. The deal is expected to close on March 14 ...

DENVER, March 6, 2025 /PRNewswire/ -- Evio Pharmacy Solutions proudly announces the addition of Wellmark Blue Cross and Blue Shield as its sixth investor and owner health plan. This new ...

For more than 25 years, Emergent has responded with solutions to complex and urgent public health threats with preparedness efforts and active responses. However, the company needed to reduce its ...

2025 Gross Margin Guidance: 48% to 51%. 2025 Q1 Revenue Guidance: $200 million to $240 million. Emergent BioSolutions Inc (NYSE:EBS) completed the stabilization phase of their multi-year ...

EMERGENT BIOSOLUTIONS ($EBS) posted quarterly earnings results on Monday, March 3rd. The company reported earnings of $0.05 per share, beating estimates of -$0.50 by ...

Emergent Biosolutions (EBS) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.35 per share. This compares to loss of $0.77 per share a year ago.